TruNativ secured $30 million in a Series B round led by OrbiMed.
- Amount
- $30M
- Stage
- Series B
- Announced
- 17 June 2026
- Lead
- OrbiMed
- Use of funds
- Nationwide distribution expansion across D2C, quick commerce, modern trade, pharmacy and retail channels, plus ingredient business expansion.
- Checked
- Amount and date matched across 2 press sources